Journal Maturitas publishes position statement on testosterone replacement therapy in the aging male‏

Journal Maturitas today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) covering testosterone replacement therapy in the aging male.

Late-onset hypogonadism (LOH) represents a common clinical entity in older men. It is characterized by the presence of symptoms (most usually of a sexual nature, such as decreased libido, decreased spontaneous erections and erectile dysfunction) in combination with low serum testosterone concentrations. Whether testosterone (TRT) should be offered to those individuals is still under extensive debate because of the uncertainties regarding risk of cardiovascular disease and prostate cancer. The position statement provides a practical guide to the use of testosterone replacement in older men.

The overall conclusion is that a general policy around offering TRT to all aging men with low testosterone concentrations is not recommended. It is always advisable to encourage older men with LOH to undertake lifestyle modifications, including weight loss, increasing exercise, stopping smoking and reducing alcohol intake before considering starting TRT. The assessment procedure should include individual evaluation of co-morbidities and careful risk versus benefit estimation; TRT should be very carefully weighed up in testosterone deficient with or without pre-existing heart disease, until evidence from large randomized prospective trials regarding cardiovascular safety becomes available.

Older men should be able to discuss therapy with their health professional so that shared and informed decisions can be made.


Explore further

Doctors urged to be cautious when treating low testosterone

More information: Manuel Neves-e-Castro et al. EMAS position statement: The ten point guide to the integral management of menopausal health, Maturitas (2015). DOI: 10.1016/j.maturitas.2015.02.003
Journal information: Maturitas

Provided by Elsevier
Citation: Journal Maturitas publishes position statement on testosterone replacement therapy in the aging male‏ (2015, November 18) retrieved 16 September 2019 from https://medicalxpress.com/news/2015-11-journal-maturitas-publishes-position-statement.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more